Abstract:The use of hydrogel-based contact lens materials holds promise for ophthalmic drug delivery by increasing drug residence time, improving drug bioavailability, reducing administration frequency, and enhancing special site targeting. Issues such as ease of manufacturing, lens comfort and appropriate release kinetics must be considered. Furthermore, the high water content of hydrogel materials can result in rapid and poorly controlled release kinetics. Herein, we modified common hydrogels used in contact lens manufacturing with phenylboronic acid (PBA). PBA addresses these material design issues since boronate esters are easily formed when boron acid and diols interact, opening up a pathway for simple modification of the model lens materials with saccharide based wetting agents. The wetting agents have the potential to improve lens comfort. Furthermore, the hydrophobicity of PBA and the presence of diols can be useful to help control drug release kinetics. In this work, polymerizable 3-(acrylamido)phenylboronic acid (APBA) was synthesized and incorporated into various hydrogels used in contact lens applications, including poly(2-hydroxyethylmethacrylate) (PHEMA), polyvinylpyrrolidone (PVP) and poly( N , N- dimethyl acrylamide) (PDMA) using UV induced free radical polymerization. The APBA structure and its incorporation into the hydrogel materials were confirmed by NMR and FTIR. The materials were shown to interact with and bind wetting agents such as hyaluronan (HA) and hydroxypropyl guar (HPG) by simple soaking in an aqueous solution. The equilibrium water content of the modified materials was characterized, demonstrating that most materials are still in the appropriate range after the introduction of the hydrophobic PBA. The release of three model ophthalmic drugs with varying hydrophilicity, atropine, atropine sulfate and dexamethasone, was examined. The presence of PBA in the materials was found to promote sustained drug release due to its hydrophobic nature. The results suggest that the modification of the materials with PBA was able to not only provide a mucoadhesive property that enhanced wetting agent interactions with the materials, but had the potential to alter drug release. Thus, the modification of contact lens materials with mucoadhesive functionality may be useful in the design of hydrogel contact lenses for ophthalmic drug release and wetting agent binding.

Recent Advances In Phenylboronic Acid-Based Gels With Potential For Self-Regulated Drug Delivery

Boronic Acid as Glucose-Sensitive Agent Regulates Drug Delivery for Diabetes Treatment

Preparation of Phenylboronic Acid‐based Glucose-Responsive Hydrogels and Microneedles for Regulated Delivery of Insulin

A boronate gel-based synthetic platform for closed-loop insulin delivery systems

Advances in the Design of Phenylboronic Acid-Based Glucose-Sensitive Hydrogels

Nanoparticle-Hydrogel: A Hybrid Biomaterial System for Localized Drug Delivery

Synthesis of Hydrogel-Bearing Phenylboronic Acid Moieties and Their Applications in Glucose Sensing and Insulin Delivery

Advances in Phenylboronic Acid-Based Closed-Loop Smart Drug Delivery System for Diabetic Therapy.

Glucose-sensitive membrane with phenylboronic acid-based contraction-type microgels as chemical valves

A Comparative Study on Two Phenylboronic Acid Based Glucose-Sensitive Hydrogels.

Glucose Oxidase-Based Glucose-Sensitive Drug Delivery for Diabetes Treatment

3D-Printed Phenylboronic Acid-Bearing Hydrogels for Glucose-Triggered Drug Release

Recent advances in glucose-responsive insulin delivery systems: novel hydrogels and future applications

Glucose-sensitive poly(ether sulfone) composite membranes blended with phenylboronic acid-based amphiphilic block copolymer for self-regulated insulin release

In Situ-Forming Protein-Polymer Hydrogel for Glucose-Responsive Insulin Release.

Galactose-based polymer-containing phenylboronic acid as carriers for insulin delivery

Glucose-responsive hydrogel-based microneedles containing phenylborate ester bonds and N-isopropylacrylamide moieties and their transdermal drug delivery properties

A Porous Reservoir-Backed Boronate Gel Microneedle for Efficient Skin Penetration and Sustained Glucose-Responsive Insulin Delivery

In‐situ Forming Multipolymeric Glucose‐responsive Hydrogels

Phenylboronic acid modified hydrogel materials and their potential for use in contact lens based drug delivery

Research Advances in Phenylboronic Acid-containing Materials